Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...

In an essay for 'Women's Health,' Dr. Nora Volkow discusses the future of semaglutide weight-loss meds, and their potential ...

A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication that the market for GLP-1 drugs could likely be a lot bigger. Based on data ...

The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who just want to control ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Kidney disease is a leading cause of death in America, killing more people than breast cancer or prostate cancer.

Diabetes is the eighth leading cause of death in the US and can lead to other conditions, including kidney failure, ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA ...

The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million—over four ...